Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
Open Access
- 16 December 2018
- journal article
- review article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 47 (1) , 31-43
Abstract
Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy and may lead to severe visual loss. In this review, we describe the pathophysiology of DMO and review current therapeutic options such as macular laser photocoagulation, anti-vascular endothelial growth factor agents, and steroid implants with a focus on the new fluocinolone acetonide implant, ILUVIEN®. The results of the Fluocinolone Acetonide in Diabetic Macular Edema (FAME) studies are also presented together with the results of real-world studies to support the clinical use of ILUVIEN® in achieving efficient resolution of DMO and improving vision and macular anatomy in this challenging group of patients.Keywords
This publication has 55 references indexed in Scilit:
- Aqueous Levels of Fluocinolone Acetonide after Administration of Fluocinolone Acetonide Inserts or Fluocinolone Acetonide ImplantsOphthalmology, 2013
- Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular EdemaOphthalmology, 2012
- Ranibizumab for Diabetic Macular EdemaOphthalmology, 2012
- Ethnic Variations in the Prevalence of Diabetic Retinopathy in People with Diabetes Attending Screening in the United Kingdom (DRIVE UK)PLOS ONE, 2012
- Global Prevalence and Major Risk Factors of Diabetic RetinopathyDiabetes Care, 2012
- Intravitreous Delivery of the Corticosteroid Fluocinolone Acetonide Attenuates Retinal Degeneration in S334ter-4 RatsInvestigative Ophthalmology & Visual Science, 2010
- Photoreceptor Neuroprotection in RCS Rats via Low-Dose Intravitreal Sustained-Delivery of Fluocinolone AcetonideInvestigative Ophthalmology & Visual Science, 2009
- Fluocinolone Inhibits VEGF Expression via Glucocorticoid Receptor in Human Retinal Pigment Epithelial (ARPE-19) Cells and TNF-α–Induced Angiogenesis in Chick Chorioallantoic Membrane (CAM)Journal of Ocular Pharmacology and Therapeutics, 2009
- Inhibitory Effects of Anti-Inflammatory Drugs on Interleukin-6 Bioactivity.Biological and Pharmaceutical Bulletin, 2001
- The Wisconsin Epidemiologic Study of Diabetic Retinopathy XVOphthalmology, 1995